Copy
November 2021

Controlling AML Maturation Can Reduce Disease Relapse

A promising approach to the treatment of acute myeloid leukaemia (AML) has been discovered by AML researchers at the Australian Centre for Blood Diseases. AML is a type of cancer that affects immature progenitor cells (which haven't yet differentiated into a specialised white blood cell type) living in bone marrow.

Continue reading »

Monash Researchers Bond with Donors to Fight Rare Cancers

The Aftershock has joined forces on a research project into lethal oesophageal cancer with Professor Wendy Brown, Alfred Hospital surgeon, researcher and Head of Monash University’s Department of Surgery.

Continue reading »

Healthcare Worker Wellbeing Centre

While looking after the mental health and wellbeing of our healthcare workers has always been important, the pandemic has made this an immediate priority for our health sector. Never has it been more important to care for your own mental health and wellbeing and for that of your employees, colleagues, family members or loved ones.

For healthcare worker wellbeing resources and support activities visit Safer Care Victoria

Help Your Patients Get Factsinated

You can direct people affected by cancer to the frequently asked questions on the Cancer Council Victoria website, which explain the increased risk of COVID-19 for people with cancer, addresses vaccine misinformation and encourages people to contact our cancer nurses on 13 11 20 for information and support. Get the facts on all things cancer and COVID-19 »

Guides to Best Cancer Care - Now Available

Cancer Care, formerly named What to Expect Guides, are a summary version of the Optimal Care Pathways (2nd edition) which were released earlier in 2021.

Download the guides »

COVID-19 Recovery: Implications for Cancer Care

The COVID-19 pandemic has prompted unprecedented changes in cancer care across the cancer care pathway and in many parts of the oncology sector. Some new or modified healthcare practices will be of long-term value in improving quality and resilience in cancer care.
COVID-19 Recovery: Implications for cancer care describes:

  • elements of cancer care which have changed during the COVID-19 pandemic
  • the impacts of these changes
  • targeted strategies (at the system-level, service-level, practitioner-level, and patient-level) to retain, enhance, and embed high-value changes into practice.
Find out more »

Culturally Safe Communication Skills – Tips for Non-Indigenous Health Professionals

This new resource from Cancer Australia comprises a series of short videos and a key messages tip sheet providing practical advice for cancer care specialists to optimise culturally safe and responsive communication with Aboriginal and Torres Strait Islander patients, their families and carers. 

Find out more »

Cancer Support Referral for Health Professionals

Cancer Council’s nurses provide information and support to people affected by cancer. If you have a patient or carer that needs support, please fill in the referral form below and one of our cancer nurses will contact them to see how we can help. In addition, please let them know that they, or anyone affected by cancer can call our nurses on 13 11 20 (cost of a local call), Monday to Friday, 9-5pm.

MPCCC Communications Manager

An exciting opportunity has become available for a part-time Communications Manager to join the Monash Partners Comprehensive Cancer Consortium (MPCCC). You will work alongside the MPCCC Chief Executive, and MPCCC Chief Operating Officer to play a key role in delivering MPCCC’s strategic priorities through the development and implementation of its Communication and Public Relations Plan.

More information and to apply »

VCCC Alliance - Seeking MPCCC Co-Chair for Penile and Testicular Cancer Forum

The VCCC Alliance is seeking expressions of interest from amongst the MPCCC clinical community to co-Chair a regular, ongoing, state-wide penile and testicular cancer forum for clinicians and researchers with an interest and expertise in these areas. 

Applications will close on 21 December. To express your interest in this opportunity or if have any questions, please contact: Jessica Freeman: Jessica.freeman@unimelb.edu.au

More information »

MRFF - Genomics Health Futures Mission 2021 Grant Opportunity

Closes 16-Feb-2022 (Min Data 02 Feb)

Stream 1 (Targeted Call for Research): develop disease-agnostic, high throughput and scalable functional genomics platforms to increase the diagnostic rate of unresolved cases and accelerate the development of experimental therapeutics
Maximum grant value is $3 million. Total Grant pool $20M
Grants up to 5 years

Stream 2 (Targeted Call for Research): develop new models of genomic newborn screening.
Maximum grant value is $3 million. Total Grant pool $12M
Grants up to 5 years

Stream 3 (Targeted Call for Research): through a competitively selected national consortium, conduct research addressing emerging ethical, legal and social issues associated with the governance of clinical and genomic datasets.
Maximum grant value is $5 million.Total Grant pool $5M  
Grants up to 5 years

Stream 4 (Targeted Call for Research): through a competitively selected national consortium, conduct research to develop effective approaches for responsible, culturally appropriate and nationally consistent involvement of Aboriginal and/or Torres Strait Islander people in genomics research and clinical practice
Maximum grant value is $5 million.Total Grant pool $5M  
Grants up to 5 years

Stream 5 (Targeted Call for Research): through a competitively selected national consortium, conduct research to enrich genomics databases to support the inclusion of culturally and linguistically diverse groups in genomics research, and equitable benefit from genomics in health
Maximum grant value is $10 million.Total Grant pool $10M  
Grants up to 5 years

Stream 6 (Incubator): conduct small-scale development projects to establish feasible, evidence-based approaches for population cohort research, focusing on culturally and linguistically diverse groups, including:
Maximum grant value is $1 million.Total Grant pool $4M  
Grants up to 2 years

More information and to apply »

MRFF - 2021 Stem Cell Therapies Grant Opportunity

Stream 1 (Accelerator): developing novel stem cell-based therapies that have the potential to transform clinical care (see guidelines for full details)
Grants up to $7M for up to 5 years

Stream 2 (Accelerator): evaluating and performing pre-clinical screening of new therapeutics using human tissues made from stem cells. (see guidelines for full details)
Grants up to $5M for up to 5 years

Closing date 23 February 2022

More information »

MRFF - 2021 Dementia, Ageing and Aged Care Grant Opportunity

Stream 1 (Accelerator): identifying and implementing interventions to extend healthy, active years of life.

Stream 2 (Targeted Call for Research): implementing appropriate support approaches that reduce stigma associated with dementia and enable better outcomes for older people, including those in vulnerable populations.

Stream 3 (Targeted Call for Research): improving the consistency and quality of care for older Australians across all care settings

Stream 4 (Incubator): supporting the development of more effective, evidence-based care approaches using data for older Australians in care.

Minimum data:  02 February 2022 Closing date 16 February 2022  

More information »

 

MPCCC Precision Oncology Seminar

“The evolving role of molecular markers in the management of patients with thyroid cancer”

Presented by Dr James Lee, Endocrine Surgeon, Monash Health and Alfred Health

Molecular markers have been playing an increasing role in the management of patients with thyroid cancer – from diagnosis, prognosis, to treatment or advanced disease. In this seminar, A/Prof James Lee will provide an overview of the evolving role of molecular markers in the management of patients with thyroid cancer.

When: Thursday 9 December
Time: 1pm to 2pm
Where: Online
More information/Register »

Living Well with Cancer: For People Affected by Cancer
When: Monday 29 November
Time: 10am to 12pm
Where: Online
More information/Register »

Reprogramming the Tumour Microenvironment of Pancreatic Cancer
Join Dr Ashleigh Poh, Olivia Newton John Cancer Research Institute, to hear about the exciting new study that supports Hematopoietic Cell Kinase (HCK) as a new therapeutic to boost treatment response in pancreatic cancer.
When: Monday 29 November
Time: 1pm to 2pm
Where: Online
More information/Register »

VCCC Alliance Consumer Engagement Forum 2021 Consumer Advocacy: An Untapped Resource
Unlock research funding and maximise professional education potential. Professor Sanchia Aranda AM, Deputy Chair VCCC Alliance, will open this insightful interactive program featuring discussions, practical examples and case studies.
When: Friday 3 December
Time: 10am to 12pm
More information/Register »

VCCC Alliance Consumers as active partners in research: workshop for researchers
When: 7 and 14 December
Time: 12pm to 2pm
Where: Online
More information/Register »
 

MPCCC Precision Oncology Seminars are recorded and available to watch on YouTube at any time. Catch up on presentations from Professor Melissa Southey, Professor Tony Purcell, Associate Professor Joseph Rosenbluh and more. Watch now »
 

Hereditary Endocrine Tumors and Associated Syndromes: A Narrative Review for Endocrinologists and Endocrine Surgeons Read article »

Posttreatment Surveillance Challenges in the Era of Precision Medicine Read article »

A Combination of Clioquinol, Zinc and Copper Increases the Abundance and Function of Breast Cancer Resistance Protein in Human Brain Microvascular Endothelial Cells Read article »

Clinical activity of durvalumab for patients with advanced mismatch repair-deficient and repair-proficient endometrial cancer. A nonrandomized phase 2 clinical trial Read article »

Do ethnic patients report longer lung cancer intervals than Anglo-Australian patients?: Findings from a prospective, observational cohort study Read article »

It doesn't stop at validation: patient reported outcome measures require ongoing and iterative development Read article »

Monash Partners Comprehensive Cancer Consortium (MPCCC) is a strategic alliance of health service and research organisations working in partnership to improve cancer outcomes through integrated, collaborative and innovative research, service improvement and clinical care programs. We are a consortium made up of clinical, research and allied partner organisations. 
Clinical partners
Alfred Health; Monash Health; Eastern Health; Peninsula Health; 
Cabrini Health; Epworth HealthCare

Research partners
Monash University; Hudson Institute of Medical Research

Allied partners
Southern Melbourne Integrated Cancer Service (SMICS); 
Monash Partners Academic Health Science Centre (Monash Partners).
Twitter
LinkedIn
If you would like to contribute to the MPCCC e-Newsletter email info@monashpartnersccc.org
Copyright © 2021 MPCCC, All rights reserved.